Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders-Reference-Cited by-同舟云学术

Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders

Published:2018-09-27 Issue:5 Volume:144 Page:1135-1146
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hofmann Susanne¹²,Schmitt Michael¹^ORCID,Götz Marlies²,Döhner Hartmut²,Wiesneth Markus³,Bunjes Donald²,Greiner Jochen²⁴^ORCID

Affiliation:

1. Clinic for Internal Medicine V; University of Heidelberg; Heidelberg Germany

2. Clinic for Internal Medicine III; University of Ulm; Ulm Germany

3. German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm; Ulm Germany

4. Department of Internal Medicine; Diakonie Hospital Stuttgart; Stuttgart Germany

Funder

Baustein-Förderung, University of Ulm and German Research Foundation (DFG)

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31753/fullpdf

Reference50 articles.

1. Graft-versus-leukemia reactions after bone marrow transplantation;Horowitz;Blood,1990

2. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients;Kolb;Blood,1990

3. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients;Kolb;Blood,1995

4. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect;Barrett;Bone Marrow Transplant,1998

5. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed;Annals of Hematology;2024-09-11

2. Modified Prophylactic Donor Lymphocyte Infusion (DLI) in an Adult T Cell Lymphoma/Leukemia (ATLL) Patient—Modality of Relapse Prevention;Diseases;2024-09-11

3. Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed;2023-11-26

4. Pre-emptive and prophylactic donor lymphocyte infusion following allogeneic stem cell transplantation;International Journal of Hematology;2023-04-04

5. An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes;Cytotherapy;2022-04